SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-062609
Filing Date
2020-12-09
Accepted
2020-12-09 18:57:39
Documents
2
Period of Report
2020-12-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4301
2 POA DOCUMENT poa.txt EX-24.3_949295 3335
  Complete submission text file 0001209191-20-062609.txt   9015
Mailing Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142
Business Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142 617-425-9200
Oncorus, Inc. (Issuer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCORUS, INC. 50 HAMPSHIRE STREET, SUITE 401 CAMBRIDGE MA 02139
Business Address
Harbin Stephen (Reporting) CIK: 0001835251 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39575 | Film No.: 201378990